...Those rapscallions at Goldman Sachs are at it again, pulling a fastie on the Australian lithium sector with a call that prices could yet go lower.
For anyone playing at home, spot spodumene prices have now fallen over 75% this year and we’re a day out from knowing if the price quoted by Fastmarkets, one of the prices used as a benchmark by Aussie producers, is going to drop again.
It’s currently paying US$1650/t, with chemical prices in China down similarly to ~US$19,400/t for lithium hydroxide and ~US$20,400/t for lithium carbonate.
A broken clock is of course right twice a day and Goldman has been bearish on lithium for a LOOOOOONNNGGG time. They say it’s “too early to call the bottom of the lithium bear market”, which they obviously would, having called 2024 lithium prices of US$11,000/t back in late 2022, compared to market consensus at the time of ~US$29,000/t.
...
The next few weeks are going to be very interesting in terms of who is showing up on the AKE registry and whether the reverse takeover of AKE by Livent goes into mainstream media and sets off a proper debate about selling out an Australian Tier 1 assets.
The good news is that AKE DOES NOT need a knight in shining armor to block the deal.
We small retail shareholders have enough voting power to trigger the 50% rule by saying NO to the merger. I am pretty sure, some of the major super funds are also against the crappy, unfair deal.
It would be nice to stick it to the BEOT for once! In particular Goldman Sachs Group (the former home of Livent CEO Paul Graves). GS is predicting Li raw material oversupply and further price drops.
VOTE AGAINST THE REVERSE TAKE OVER! F@#$ the merger!
***This is not financial advice and my opinion only****
AKE Price at posting:
$8.88 Sentiment: Hold Disclosure: Held